IQVIA Holdings Inc. IQV
275.58 USD -3.26 (-1.17%)
Nov 10, 2026, 3:16 PM EST
274.10 Day range 278.04
156.66 52-week range 279.36
- YTD
- +22.26%
- 1 year
- +29.35%
News
fool.com IQVIA: 3 Key Takeaways for Long-Term Investors Net new clinical bookings reached $3.2 billion in the third quarter. Last 12-month net new bookings increased 14% to $11.7 billion.
benzinga.com TD Cowen Maintains Buy on IQVIA Holdings, Raises Price Target to $307 TD Cowen analyst Charles Rhyee maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $288 to $307.
benzinga.com JP Morgan Maintains Overweight on IQVIA Holdings, Raises Price Target to $325 JP Morgan analyst Casey Woodring maintains IQVIA Holdings (NYSE:IQV) with a Overweight and raises the price target from $295 to $325.- benzinga.com Truist Securities Maintains Buy on IQVIA Holdings, Raises Price Target to $346 Truist Securities analyst Jailendra Singh maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $329 to $346.
benzinga.com Evercore ISI Group Maintains Outperform on IQVIA Holdings, Raises Price Target to $310 Evercore ISI Group analyst Elizabeth Anderson maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $290 to $310.- benzinga.com Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $328 Baird analyst Eric Coldwell maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $324 to $328.
benzinga.com IQVIA Hldgs Q3 2026 Earnings Call Transcript IQVIA Hldgs (NYSE:IQV) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…- benzinga.com IQVIA Holdings Raises FY2026 Adj EPS Guidance from $12.80-$13.00 to $12.90-$13.00 vs $12.96 Est; Raises FY2026 Sales Guidance from $17.275B-$17.475B to $17.350B-$17.500B vs $17.419B Est IQVIA Holdings (NYSE:IQV) raises FY2026 Adj EPS guidance from $12.80-$13.00 to $12.90-$13.00 vs $12.96 analyst estimate. Raises FY2026 sales outlook from $17.275 billion-$17.475 billion to $17.350…
benzinga.com Stifel Maintains Buy on IQVIA Holdings, Raises Price Target to $303 Stifel analyst Shlomo Rosenbaum maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $276 to $303.
benzinga.com IQVIA Expands Partnership Veeva Systems On Enterprise Standard Applications That Will Be Used Across IQVIA Clinical Development Studies IQVIA (NYSE:IQV) and Veeva Systems (NYSE:VEEV) today announced an expansion of their partnership with the selection of Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard…
benzinga.com Mizuho Maintains Outperform on IQVIA Holdings, Raises Price Target to $300 Mizuho analyst Ann Hynes maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $275 to $300.- benzinga.com Barclays Maintains Overweight on IQVIA Holdings, Raises Price Target to $300 Barclays analyst Luke Sergott maintains IQVIA Holdings (NYSE:IQV) with a Overweight and raises the price target from $275 to $300.
benzinga.com RBC Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $319 RBC Capital analyst Ryan Halsted maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $247 to $319.
benzinga.com Truist Securities Reiterates Buy on IQVIA Holdings, Raises Price Target to $329 Truist Securities analyst Jailendra Singh reiterates IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $300 to $329.- benzinga.com Morgan Stanley Maintains Equal-Weight on IQVIA Holdings, Raises Price Target to $270 Morgan Stanley analyst Kallum Titchmarsh maintains IQVIA Holdings (NYSE:IQV) with a Equal-Weight and raises the price target from $240 to $270.
- benzinga.com JP Morgan Maintains Overweight on IQVIA Holdings, Raises Price Target to $285 JP Morgan analyst Casey Woodring maintains IQVIA Holdings (NYSE:IQV) with a Overweight and raises the price target from $225 to $285.
- benzinga.com Stifel Maintains Buy on IQVIA Holdings, Raises Price Target to $276 Stifel analyst Shlomo Rosenbaum maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $220 to $276.
- benzinga.com TD Cowen Maintains Buy on IQVIA Holdings, Raises Price Target to $288 TD Cowen analyst Charles Rhyee maintains IQVIA Holdings (NYSE:IQV) with a Buy and raises the price target from $233 to $288.
benzinga.com RBC Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $247 RBC Capital analyst Ryan Halsted maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $221 to $247.- benzinga.com BMO Capital Maintains Outperform on IQVIA Holdings, Raises Price Target to $270 BMO Capital analyst Sean Dodge maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $210 to $270.
- benzinga.com Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $287 Baird analyst Eric Coldwell maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $252 to $287.
benzinga.com Nasdaq 100 Enters Correction, SanDisk Sinks Over 50% From Peak: Stock Market Today A deepening chip rout drags the Nasdaq while Coca-Cola and Sherwin-Williams beats power the Dow; oil dives 5% on Iran diplomacy as the Fed meets.
benzinga.com Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On Tuesday U.S. stocks mixed, Dow Jones up 300 points. Shares of Sherwin-Williams rose 7.8% after reporting better-than-expected earnings and raising FY26 guidance.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Gossamer Bio (NASDAQ:GOSS) shares moved upwards by 47.2% to $0.29 during Tuesday's pre-market session. The company's market cap stands at $97.4 million. Prelude Therapeutics (NASDAQ:PRLD)…- benzinga.com IQVIA Hldgs Q2 Adj. EPS $3.15 Beats $3.03 Estimate, Sales $4.368B Beat $4.301B Estimate IQVIA Hldgs (NYSE:IQV) reported quarterly earnings of $3.15 per share which beat the analyst consensus estimate of $3.03 by 3.96 percent. This is a 12.1 percent increase over earnings of $2.81 per…
- benzinga.com IQVIA Holdings Raises FY2026 Adj EPS Guidance from $12.65-$12.95 to $12.80-$13.00 vs $12.80 Est; Raises FY2026 Sales Guidance from $17.150B-$17.350B to $17.275B-$17.475B vs $17.286B Est IQVIA Holdings (NYSE:IQV) raises FY2026 Adj EPS guidance from $12.65-$12.95 to $12.80-$13.00 vs $12.80 analyst estimate. Raises FY2026 sales outlook from $17.150 billion-$17.350 billion to $17.275…
- benzinga.com Mizuho Maintains Outperform on IQVIA Holdings, Raises Price Target to $230 Mizuho analyst Ann Hynes maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $215 to $230.
benzinga.com Palo Alto To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, please see our analyst ratings page.
benzinga.com Baird Maintains Outperform on IQVIA Holdings, Raises Price Target to $249 Baird analyst Eric Coldwell maintains IQVIA Holdings (NYSE:IQV) with a Outperform and raises the price target from $230 to $249.
benzinga.com Micron To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday Top analysts changed outlook on top names: Intuit downgraded, Alkermes price target raised, Carmax target increased, Sezzle target up, Biogen target raised, Progressive target cut.- benzinga.com Delta Air Lines To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday Top Wall Street analysts changed outlook on top names. Baird raised prices for Ryder System and J B Hunt, Needham for Glaukos, B of A for CSX, Morgan Stanley for Charles River, and Bernstein for…
- benzinga.com Morgan Stanley Downgrades IQVIA Holdings to Equal-Weight, Lowers Price Target to $200 Morgan Stanley analyst Kallum Titchmarsh downgrades IQVIA Holdings (NYSE:IQV) from Overweight to Equal-Weight and lowers the price target from $225 to $200.
- benzinga.com IQVIA Advances Strategic Collaboration With Kexing Biopharm To Support Global, Multi-Product Biosimilar Development And Commercialization Program IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, is advancing its strategic…
- benzinga.com IQVIA Announces Additional $2B Buyback Plan IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries,…
benzinga.com Earnings Scheduled For May 5, 2026 - benzinga.com IQVIA Holdings Raises FY2026 Adj EPS Guidance from $12.55-$12.85 to $12.65-$12.95 vs $12.71 Est; Affirms FY2026 Sales Guidance of $17.150B-$17.350B vs $17.241B Est. IQVIA Holdings (NYSE:IQV) raises FY2026 Adj EPS guidance from $12.55-$12.85 to $12.65-$12.95 vs $12.71 analyst estimate. Affirms FY2026 sales outlook from $17.150 billion-$17.350 billion to $17.150…
- benzinga.com IQVIA Hldgs Q1 Adj. EPS $2.90 Beats $2.82 Estimate, Sales $4.151B Beat $4.100B Estimate. IQVIA Hldgs (NYSE:IQV) reported quarterly earnings of $2.90 per share which beat the analyst consensus estimate of $2.82 by 2.84 percent. This is a 7.41 percent increase over earnings of $2.70 per…
benzinga.com Gartner, Stellantis, And Novo Nordisk Are Among Top 10 Large Cap Losers Last Week (Feb. 2-Feb. 6): Are the Others in Your Portfolio? Large-cap losers last week (Feb. 2–Feb. 6) were hit by weak earnings/guidance and analyst downgrades—led by Stellantis, Gartner, PayPal, Reddit, and Novo Nordisk.- benzinga.com Earnings Scheduled For February 5, 2026
benzinga.com This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday 
benzinga.com Nasdaq 100 Hits 26,000, Gold Falls Below $4,000: What's Moving Markets Tuesday? Tech stocks hit new highs as the Nasdaq 100 rallies 0.7% midday. Investors eye a Fed rate cut, Trump-Xi meeting, and major tech earnings.
benzinga.com Earnings Scheduled For October 28, 2025 
benzinga.com This Tractor Supply Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday 
benzinga.com Firefly Stock Jumps As Nvidia Partnership Boosts AI-Driven EEG Technology For Neurological Care Firefly Neuroscience (AIFF) stock up after unveiling CLEAR Platform powered by Nvidia's (NVDA) L40S GPU for improved EEG data quality and processing speed.
benzinga.com David Tepper's Hedge Fund Bets On Intel, UnitedHealth; Cuts Position In Four Mag 7 Stocks David Tepper sold casino stocks and bought airline stocks in the second quarter. Here's a look at the changes made to the Appaloosa hedge fund.
benzinga.com Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio? Medpace, ICON, and West Pharma led last week's large-cap rally, driven by strong earnings beats and upgraded guidance.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com Lockheed, General Motors Tumble, Gold Hits 1-Month Highs: What's Moving Markets Tuesday? It was a quiet Tuesday on Wall Street, as major indexes edged lower with investors pausing ahead of a critical wave of tech earnings.
benzinga.com D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday - benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session